's () Sean Hall tells Proactive that the company is building a cannabis-based drug that is the size of a nanoparticle.
Hall adds that the company is currently intent on marketing the product in around 18 countries, including the EU, the US, Canada, and Australia.
Hall also says that the firm is currently talking to several pharmaceutical firms, two of which are of "significant note".
Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
Meet Alliance Pharma PLC, IXICO PLC, Benchmark Holdings PLC, Clinigen Group PLC and Shield Therapeutics PLC at our event,
London , 24 January 2019.
Register here »